National Medical Care Company Stock

Equities

4005

SA139051UIH0

Healthcare Facilities & Services

End-of-day quote Saudi Arabian S.E. 06:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
186.8 SAR +0.21% Intraday chart for National Medical Care Company -5.37% +7.11%
Sales 2024 * 1.37B 367M Sales 2025 * 1.49B 398M Capitalization 8.38B 2.24B
Net income 2024 * 293M 78.17M Net income 2025 * 350M 93.37M EV / Sales 2024 * 5.67 x
Net cash position 2024 * 582M 155M Net cash position 2025 * 781M 208M EV / Sales 2025 * 5.09 x
P/E ratio 2024 *
29.2 x
P/E ratio 2025 *
24.4 x
Employees -
Yield 2024 *
0.93%
Yield 2025 *
1.02%
Free-Float 50.8%
More Fundamentals * Assessed data
Dynamic Chart
Saudi Arabia's National Medical Care Co Declares FY23 Dividend MT
National Medical Care Wins SAR380 Million Contract for Patient Care Services MT
National Medical Care Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI
National Medical Care Co. Announces Purchase Buying A Land in the Value of SAR 131,793,000 CI
National Medical Care Company acquired Chronic Care Specialized Medical Hospital Company from Saudi Medical Care Group. CI
National Medical Care Company Reports Earnings Results for the Third Quarter Ended September 30, 2023 CI
National Medical Care Company Reports Earnings Results for the Second Quarter Ended June 30, 2023 CI
National Medical Care Company completed the acquisition of Jiwar Medical Services Company from SmartMed. CI
National Medical Care Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
National Medical Care Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
National Medical Care Company signed a non-binding memorandum of understanding to acquire Jiwar Medical Services Company from SmartMed for SAR 65 million. CI
National Medical Care Company Reports Earnings Results for the Third Quarter Ended September 30, 2022 CI
National Medical Care Company Announces Executive Appointments CI
National Medical Care Company Approves Formation of the Audit Committee CI
National Medical Care Company Reports Earnings Results for the Second Quarter Ended June 30, 2022 CI
More news
1 day+0.21%
1 week-5.37%
Current month+0.54%
1 month-3.01%
3 months-0.43%
6 months+50.65%
Current year+7.11%
More quotes
1 week
182.40
Extreme 182.4
198.20
1 month
176.60
Extreme 176.6
200.80
Current year
175.20
Extreme 175.2
224.00
1 year
90.00
Extreme 90
224.00
3 years
50.70
Extreme 50.7
224.00
5 years
32.60
Extreme 32.6
224.00
10 years
31.70
Extreme 31.7
224.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 18-10-06
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 41 14-12-31
Director/Board Member - 19-09-14
Chairman - 19-05-20
More insiders
Date Price Change Volume
24-04-24 186.8 +0.21% 59,876
24-04-23 186.4 -2.51% 99,387
24-04-22 191.2 +1.81% 147,470
24-04-21 187.8 -1.78% 54,639
24-04-18 191.2 -4.21% 127,050

End-of-day quote Saudi Arabian S.E., April 23, 2024

More quotes
National Medical Care Company JSC is a Saudi-Arabia based company engaged in the provision of medical services and the establishment, ownership, operation and management of hospitals and health care units and centers, as well as the wholesale and retail trade of drugs, medical equipment and supplies. The Company’s main activities include inpatient and surgeries, outpatient clinics, other medical sections, pharmacies, and general administration and pharmaceutical medical distribution. The Company manages two hospitals include Riyadh Care Hospital, which has a capacity of 340 beds and the National Hospital, which has a capacity of 124 beds. The Company’s hospitals provide services through its departments, including Surgery, Internal diseases, Pediatrics, Gynecology, Dental, Ambulance, Occupational Hazards and Inpatients Diseases, among others. The Company also has stake in Pharmaceutical & Medical Distribution Company.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
186.8 SAR
Average target price
204.4 SAR
Spread / Average Target
+9.44%
Consensus